The Doctors Lounge - Hematology via MedWorm.com MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'The Doctors Lounge - Hematology' source. Sat, 10 Oct 2009 19:37:54 +0100 Study of leukemia survivors stresses value of long-term follow-up http://www.medworm.com/index.php?rid=1401072&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.doctorslounge.com%2Fhematology%2Fnews%2Fleukemia_second_tumors.shtml Survivors of acute lymphoblastic leukemia are increasingly likely to develop second tumors during adulthood. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=1401072 Mon, 18 Jun 2007 08:38:26 +0100 1401072 Test for p53 may help prescreen patients for proteosome inhibitors http://www.medworm.com/index.php?rid=1401073&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.doctorslounge.com%2Fhematology%2Fnews%2Fproteosome_inhibitors_p53.shtml Test may help prescreen cancer patients to see if they are suitable candidates for proteasome inhibitors. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=1401073 Fri, 09 Mar 2007 07:41:16 +0100 1401073 Role for proteomics in identifying hematologic malignancies http://www.medworm.com/index.php?rid=1401074&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.doctorslounge.com%2Fhematology%2Fnews%2Fproteomics_mds.shtml Scientists have identified a set of biomarkers that could help clinicians identify myelodysplastic syndromes. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=1401074 Wed, 17 Jan 2007 04:06:57 +0100 1401074 Home care programme for bone marrow transplanted patients http://www.medworm.com/index.php?rid=1401075&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.doctorslounge.com%2Fhematology%2Fnews%2Fhome_care_bmt.shtml A clinical trial started five years ago allows patients undergoing BMT to avoid four weeks of hospitalisation. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=1401075 Mon, 23 Oct 2006 07:06:33 +0100 1401075 Study finds new drug is potent treatment for CML http://www.medworm.com/index.php?rid=127522&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.doctorslounge.com%2Fhematology%2Farticles%2Fcml_drug%2Findex.htm AMN107, is about 20 times more potent than Gleevec and is effective in treating Gleevec-resistant disease. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=127522 Mon, 31 Jul 2006 02:28:03 +0100 127522 New benchmark study of unrelated bone marrow transplantation for leukemia http://www.medworm.com/index.php?rid=127520&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.doctorslounge.com%2Fhematology%2Farticles%2Funrelated_transplant%2Findex.htm Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=127520 Mon, 31 Jul 2006 02:28:03 +0100 127520 Aspirin may not provide optimum anti-coagulation for all patients http://www.medworm.com/index.php?rid=127518&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.doctorslounge.com%2Fhematology%2Farticles%2Faspirin_failure%2Findex.htm Evidence is growing that some people will not respond to the anti-coagulant action of aspirin despite its regular intake. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=127518 Mon, 31 Jul 2006 02:28:03 +0100 127518 FDA approves extended dosing of Aranesp http://www.medworm.com/index.php?rid=127515&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.doctorslounge.com%2Fhematology%2Farticles%2Fanemia%2Fchemotherapy_induced%2Findex.htm FDA has approved every-3-week dosing of Aranesp (darbepoetin alfa) for treatment of chemotherapy - induced anemia. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=127515 Mon, 31 Jul 2006 02:28:03 +0100 127515 Canadian scientist invents alternative for IV immunoglobulin http://www.medworm.com/index.php?rid=127512&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.doctorslounge.com%2Fhematology%2Farticles%2Fblood_components%2Fsynthetic_immunoglobulin%2Findex.htm Costly IVIg may be replaced with synthetic product allowing better treatment for patients with life-threatening illness. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=127512 Mon, 31 Jul 2006 02:28:03 +0100 127512 Cord blood transplantation now a viable option for adult leukemia http://www.medworm.com/index.php?rid=22220&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.thedoctorslounge.net%2Fhematology%2Farticles%2Fcord_leukemia%2Findex.htm Researchers examined a new technique that combines two cord blood units from different donors for transplantation into leukemia patients. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=22220 Sat, 20 May 2006 06:00:00 +0100 22220 Study finds new drug is potent treatment for CML http://www.medworm.com/index.php?rid=22219&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.thedoctorslounge.net%2Fhematology%2Farticles%2Fcml_drug%2Findex.htm AMN107, is about 20 times more potent than Gleevec and is effective in treating Gleevec-resistant disease. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=22219 Sat, 20 May 2006 06:00:00 +0100 22219 New benchmark study of unrelated bone marrow transplantation for leukemia http://www.medworm.com/index.php?rid=22218&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.thedoctorslounge.net%2Fhematology%2Farticles%2Funrelated_transplant%2Findex.htm Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=22218 Sat, 20 May 2006 06:00:00 +0100 22218 Aspirin may not provide optimum anti-coagulation for all patients http://www.medworm.com/index.php?rid=22217&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.thedoctorslounge.net%2Fhematology%2Farticles%2Faspirin_failure%2Findex.htm Evidence is growing that some people will not respond to the anti-coagulant action of aspirin despite its regular intake. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=22217 Sat, 20 May 2006 06:00:00 +0100 22217 FDA approves extended dosing of Aranesp http://www.medworm.com/index.php?rid=22216&cid=s_29482_19_f&fid=29482&url=http%3A%2F%2Fwww.thedoctorslounge.net%2Fhematology%2Farticles%2Fanemia%2Fchemotherapy_induced%2Findex.htm FDA has approved every-3-week dosing of Aranesp (darbepoetin alfa) for treatment of chemotherapy - induced anemia. (Source: The Doctors Lounge - Hematology) The Doctors Lounge - Hematology info http://www.medworm.com/rss/comments.php?id=22216 Sat, 20 May 2006 06:00:00 +0100 22216